Roivant Sciences (ROIV) Short-Term Debt issuances (2020 - 2022)
Roivant Sciences (ROIV) posted Short-Term Debt issuances of $159.9 million for Q4 2022, little changed on a QoQ basis from $159.9 million in Q2 2022, and up 339.28% year-over-year from $36.4 million in Q4 2021.
Roivant Sciences (ROIV) Short-Term Debt issuances (2020 - 2022) Analysis & Trends
Roivant Sciences' Short-Term Debt issuances history runs 3 years deep, the most recent figure standing at $159.9 million for Q4 2022.
- Quarterly Short-Term Debt issuances rose 339.28% year-over-year to $159.9 million in Q4 2022, while the trailing twelve-month figure through Dec 2023 was $159.9 million (down 55.11% YoY) and the FY2023 annual result came in at $159.9 million, up 339.28% from the prior year.
- Short-Term Debt issuances was $159.9 million for Q4 2022 at Roivant Sciences, roughly flat from $159.9 million in the prior quarter.
- Across five years, Short-Term Debt issuances topped out at $159.9 million in Q2 2022 and bottomed at -$36.4 million in Q4 2020.
- A 3-year average of $71.2 million and a median of $36.4 million in 2021 frame the typical range for Short-Term Debt issuances.
- Annual changes were most pronounced in 2021 — Short-Term Debt issuances surged 200.0% — and 2022, when it soared 339.28%.
- Roivant Sciences' Short-Term Debt issuances stood at -$36.4 million in 2020, then jumped by 200.0% to $36.4 million in 2021, then jumped by 339.28% to $159.9 million in 2022.
- Business Quant data shows ROIV's Short-Term Debt issuances at $159.9 million in Q4 2022, $159.9 million in Q2 2022, and $36.4 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 58.20 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 159.90 Mn |
| Dec 31, 2022 | 159.90 Mn |
| Jun 30, 2022 | 159.90 Mn |
| Jun 30, 2022 | 159.90 Mn |
| Dec 31, 2021 | 36.40 Mn |
| Dec 31, 2021 | 36.40 Mn |
| Jun 30, 2021 | 36.40 Mn |
| Jun 30, 2021 | 36.40 Mn |
| Dec 31, 2020 | -36.40 Mn |
| Dec 31, 2020 | -36.40 Mn |